DK1015444T3 - Pyrimidinderivater og fremgangsmåder til fremstilling deraf - Google Patents

Pyrimidinderivater og fremgangsmåder til fremstilling deraf

Info

Publication number
DK1015444T3
DK1015444T3 DK98911242T DK98911242T DK1015444T3 DK 1015444 T3 DK1015444 T3 DK 1015444T3 DK 98911242 T DK98911242 T DK 98911242T DK 98911242 T DK98911242 T DK 98911242T DK 1015444 T3 DK1015444 T3 DK 1015444T3
Authority
DK
Denmark
Prior art keywords
processes
preparation
pyrimidine derivatives
pyrimidine
derivatives
Prior art date
Application number
DK98911242T
Other languages
Danish (da)
English (en)
Inventor
Jong Wook Lee
Bong Yong Lee
Chang Seop Kim
Seung Kyu Lee
Keun Seog Song
Song Jin Lee
Woo Jeon Shim
Man Soon Hwang
Original Assignee
Yuhan Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp Ltd filed Critical Yuhan Corp Ltd
Application granted granted Critical
Publication of DK1015444T3 publication Critical patent/DK1015444T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98911242T 1997-03-27 1998-03-24 Pyrimidinderivater og fremgangsmåder til fremstilling deraf DK1015444T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19970010862 1997-03-27
KR19970010863 1997-03-27
PCT/KR1998/000058 WO1998043968A1 (fr) 1997-03-27 1998-03-24 Nouveaux derives de pyrimidine et procedes de preparation desdits derives

Publications (1)

Publication Number Publication Date
DK1015444T3 true DK1015444T3 (da) 2003-08-18

Family

ID=26632616

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98911242T DK1015444T3 (da) 1997-03-27 1998-03-24 Pyrimidinderivater og fremgangsmåder til fremstilling deraf

Country Status (22)

Country Link
US (1) US6352993B1 (fr)
EP (1) EP1015444B1 (fr)
JP (1) JP3176379B2 (fr)
KR (1) KR100278857B1 (fr)
CN (1) CN1118464C (fr)
AR (1) AR012181A1 (fr)
AT (1) ATE241613T1 (fr)
AU (1) AU720385B2 (fr)
BR (1) BR9808070A (fr)
CA (1) CA2284795C (fr)
DE (1) DE69815126T2 (fr)
DK (1) DK1015444T3 (fr)
ES (1) ES2200324T3 (fr)
HK (1) HK1026418A1 (fr)
HU (1) HUP0000851A3 (fr)
IN (1) IN188411B (fr)
PT (1) PT1015444E (fr)
RU (1) RU2203894C2 (fr)
TR (1) TR199902383T2 (fr)
TW (1) TW542831B (fr)
UY (1) UY24938A1 (fr)
WO (1) WO1998043968A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
TW200302728A (en) 2002-02-01 2003-08-16 Novartis Ag Substituted amines as IgE inhibitors
WO2004012659A2 (fr) 2002-08-01 2004-02-12 Nitromed, Inc. Inhibiteurs nitroses de la pompe a protons, compositions et procedes d'utilisation
US20070161637A1 (en) * 2003-07-22 2007-07-12 Neurogen Corporation Substituted pyridin-2-ylamine analogues
CA2541989C (fr) * 2003-10-24 2013-10-01 Exelixis, Inc. Modulateurs des p70s6 kinases et procede d'utilisation
CN101361738A (zh) 2003-11-03 2009-02-11 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
KR101122376B1 (ko) * 2005-03-09 2012-03-26 주식회사유한양행 신규의 5,6-다이메틸피리미딘 유도체 및 그의 제조방법
US20090124645A1 (en) * 2005-10-14 2009-05-14 Neurosearch A/S Novel Pyrimidine-2,4-Diamine Derivatives and their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
MY153606A (en) 2008-08-05 2015-02-27 Daiichi Sankyo Co Ltd Imidazopyridin-2-one derivatives
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
AU2011331301A1 (en) 2010-11-15 2013-05-23 Katholieke Universiteit Leuven Antiviral condensed heterocyclic compounds
JP5980236B2 (ja) 2011-02-25 2016-08-31 ユーハン・コーポレイションＹＵＨＡＮ Ｃｏｒｐｏｒａｔｉｏｎ ジアミノピリミジン誘導体及びその製造方法
MX2014009933A (es) * 2012-02-17 2015-12-16 Abbvie Inc Diaminopirimidinas utiles como inhibidores del virus sincitial respiratorio humano (rsv).
WO2013181136A1 (fr) 2012-05-29 2013-12-05 Momentive Performance Materials Gmbh Préparation d'isocyanatosilanes
JP6412503B2 (ja) 2012-11-21 2018-10-24 ピーティーシー セラピューティクス， インコーポレイテッド 置換逆ピリミジンＢｍｉ−１阻害剤
BR112015022545A2 (pt) 2013-03-13 2017-07-18 Constellation Pharmaceuticals Inc compostos de pirazolo e os usos disso
WO2015030847A1 (fr) * 2013-08-30 2015-03-05 Ptc Therapeutics, Inc. Inhibiteurs de bmi-1 à base de pyrimidines substituées
CN104903312B (zh) * 2013-10-07 2019-01-29 卡德门企业有限公司 Rho激酶抑制剂
EP3071553A4 (fr) 2013-11-21 2017-08-02 PTC Therapeutics, Inc. Inhibiteurs de bmi-1 à base de pyridine et de pyrazine substituées
US10370360B2 (en) 2014-10-22 2019-08-06 The Board Of Regents Of The University Of Texas System Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof
CN105669642B (zh) * 2014-11-19 2020-06-09 江苏天士力帝益药业有限公司 一种盐酸洛氟普啶的制备方法
AU2017205670B2 (en) * 2016-01-04 2021-05-20 Merck Serono S.A. L-valinate of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
JP7107962B2 (ja) * 2017-04-05 2022-07-27 バイエル・クロップサイエンス・アクチェンゲゼルシャフト ２－アミノ－５－オキシアルキル－ピリミジン誘導体および望ましくない植物成長を防除するためのその使用
CN114685369B (zh) * 2022-05-17 2024-02-02 河南省科学院高新技术研究中心 一种利用离子液体制备1-甲基-1,2,3,4-四氢异喹啉的方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980781A (en) 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
US4000138A (en) 1966-03-31 1976-12-28 Imperial Chemical Industries Limited Organic compounds and compositions containing them
GB1182584A (en) 1966-03-31 1970-02-25 Ici Ltd Pyrimidine derivates and the use thereof as fungicides
GB1383409A (en) 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US4044136A (en) 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
US3956495A (en) 1973-10-30 1976-05-11 Eli Lilly And Company 2,4-Diaminoquinazolines as antithrombotic agents
US4755218A (en) 1985-12-31 1988-07-05 Monsanto Company Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
IL88507A (en) * 1987-12-03 1993-02-21 Smithkline Beckman Intercredit 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
US4966622A (en) 1988-04-12 1990-10-30 Ciba-Geigy Corporation N-phenyl-N-pyrimidin-2-ylureas
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
DE3901448A1 (de) 1989-01-19 1990-07-26 Basf Ag Emulsionscopolymerisate
EP0388838B1 (fr) 1989-03-22 1996-01-10 Ciba-Geigy Ag Parasiticide
CA2015981A1 (fr) * 1989-05-10 1990-11-10 Thomas H. Brown Composes
GB8910722D0 (en) 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
GB9012592D0 (en) 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
DE9190155U1 (de) 1990-11-06 1993-10-07 Pfizer Inc., New York, N.Y. Chinazolinderivate zur Steigerung der Antitumoraktivität
HUT65177A (en) * 1991-04-17 1994-05-02 Pfizer Process for producing antitumor activity enhancing pyrimidine derivatives and pharmaceutical preparations containing them
US5276186A (en) 1992-03-11 1994-01-04 Ciba-Geigy Corporation Process for the production of guanidine derivatives
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
ATE163647T1 (de) 1993-08-26 1998-03-15 Ono Pharmaceutical Co 4-aminopyrimidin derivate
JP3398152B2 (ja) 1993-10-12 2003-04-21 ブリストル‐マイヤーズ・スクイブ・ファーマ・カンパニー １ｎ−アルキル−ｎ−アリールピリミジンアミンおよびその誘導体
ES2201112T3 (es) 1994-08-13 2004-03-16 Yuhan Corporation Nuevos derivados de pirimidina y procedimientos para su preparacion.
CA2358479C (fr) 1996-05-04 2004-07-13 Yuhan Corporation 4-substitue-2-(4-fluorophenylamino)-5,6 dimethylpyrimidine

Also Published As

Publication number Publication date
EP1015444B1 (fr) 2003-05-28
AR012181A1 (es) 2000-09-27
HUP0000851A1 (hu) 2001-04-28
RU2203894C2 (ru) 2003-05-10
PT1015444E (pt) 2003-10-31
ES2200324T3 (es) 2004-03-01
TR199902383T2 (xx) 2000-06-21
AU6523998A (en) 1998-10-22
HUP0000851A3 (en) 2002-04-29
JP3176379B2 (ja) 2001-06-18
DE69815126T2 (de) 2004-04-08
US6352993B1 (en) 2002-03-05
CA2284795C (fr) 2004-01-20
ATE241613T1 (de) 2003-06-15
CN1118464C (zh) 2003-08-20
UY24938A1 (es) 2001-01-31
DE69815126D1 (de) 2003-07-03
KR100278857B1 (ko) 2001-01-15
AU720385B2 (en) 2000-06-01
BR9808070A (pt) 2000-03-08
WO1998043968A1 (fr) 1998-10-08
HK1026418A1 (en) 2000-12-15
IN188411B (fr) 2002-09-21
CN1251586A (zh) 2000-04-26
KR19980080789A (ko) 1998-11-25
JP2000513014A (ja) 2000-10-03
TW542831B (en) 2003-07-21
CA2284795A1 (fr) 1998-10-08
EP1015444A1 (fr) 2000-07-05

Similar Documents

Publication Publication Date Title
DK1015444T3 (da) Pyrimidinderivater og fremgangsmåder til fremstilling deraf
DK1112174T3 (da) Isosorbidholdige polyestere og fremgangsmåder til fremstiling heraf
ATE256123T1 (de) Pyrimidonderivate
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
DK0915880T3 (da) Azolotriaziner og pyrimidiner
DK0980240T3 (da) Sammensætninger med lang frigivelse og fremgangsmåde til fremstilling heraf
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
NO20001409L (no) Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
NO994791D0 (no) Nikotinamid-derivater
DK0985697T3 (da) Oxiranderivater og fremgangsmåde til fremstilling deraf
DK0740668T3 (da) Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse
ID23889A (id) Turunan-turunan piridina
NO20003067L (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
NO975977L (no) Substituerte purinderivater, fremgangsmÕter for fremstilling og anvendelse derav
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
NO20001554L (no) FremgangsmÕter og mellomprodukter nyttige for Õ fremstille antifolater
DK0977812T3 (da) Asfaltsammensætninger og fremgangsmåder til fremstilling deraf
DK1003383T3 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
ATE440854T1 (de) 5-deoxy-cytidin-derivate
DK0751132T3 (da) Pyridazinonderivater og fremgangsmåder til fremstilling af samme
NO985248D0 (no) Indolylpyrrolydenmetylpyrrolderivater og fremgangsmÕte for deres fremstilling
DE69524611T2 (de) Pyrimidon-derivate
DK1025100T3 (da) 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
DK0933373T3 (da) Terpenoidlactonforbindelser og fremgangsmåder til fremstilling deraf